World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
146
Citations
92758
World Ranking
1326
National Ranking
767

Overview

Adel K. El-Naggar is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their primary field of research is Medicine, with extensive work in subfields including Surgery, Oncology, Molecular Biology, Otorhinolaryngology, and Pulmonary and Respiratory Medicine.

The scientist has a significant focus on specific topics within oncology and head and neck diseases, including:

  • Salivary Gland Tumors Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Ear and Head Tumors
  • Head and Neck Surgical Oncology
  • Oral and Maxillofacial Pathology
  • RNA modifications and cancer
  • Tumors and Oncological Cases

El-Naggar's recent published work includes the following papers:

  • Loss of p53 drives neuron reprogramming in head and neck cancer, 2020, Nature
  • Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma, 2021, Cancer Cell
  • Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck, 2021, Clinical Cancer Research
  • Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets, 2020, Clinical Cancer Research
  • Diverse tumorigenic consequences of human papillomavirus integration in primary oropharyngeal cancers, 2021, Genome Research

They frequently collaborate with several co-authors, among whom the most frequent are:

  • Renata Ferrarotto
  • Yoshitsugu Mitani
  • Luana Guimarães de Sousa
  • Camilla O. Hoff
  • Jeffrey N. Myers

El-Naggar's research output has been published predominantly in the following venues:

  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • International Journal of Radiation Oncology*Biology*Physics
  • Cancers
  • Cancer

Best Publications

  • Comprehensive genomic characterization of head and neck squamous cell carcinomas

    Michael S. Lawrence;Carrie Sougnez;Lee Lichtenstein;Kristian Cibulskis

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally

  • WHO classification of head and neck tumours

    Adel K El-Naggar;John K. C Chan;Jennifer Rubin Grandis;隆 高田

  • Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1

    Nishant Agrawal;Mitchell J. Frederick;Curtis R. Pickering;Chetan Bettegowda

  • Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors

    Yuri E. Nikiforov;Raja R. Seethala;Giovanni Tallini;Zubair W. Baloch

  • Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

    E. Papaemmanuil;M. Cazzola;J. Boultwood;L. Malcovati

  • Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

    Gene A. Lang;Tomoo Iwakuma;Young Ah Suh;Geng Liu

  • Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy

    Libero Santarpia;Scott M Lippman;Adel K El-Naggar

  • HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

    Michael F. Press;Leslie Bernstein;Patricia A. Thomas;Lorraine F. Meisner

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

    Guido Rindi;David S. Klimstra;Behnoush Abedi-Ardekani;Sylvia L. Asa

  • Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522

    K. Kian Ang;Qiang Zhang;David I. Rosenthal;Phuc Felix Nguyen-Tan

  • Highly prevalent TERT promoter mutations in aggressive thyroid cancers

    Xiaoli Liu;Justin Bishop;Yuan Shan;Sara Isabel Pai

  • MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.

    David H.F. Teng;Rong Hu;Huai Lin;Thaylon Davis

  • Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer

    Stephen G. Swisher;Jack A. Roth;John Nemunaitis;David D. Lawrence

  • Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma

    Curtis R. Pickering;Jane H. Zhou;J. Jack Lee;Jennifer A. Drummond

  • t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway

    Giovanni Tonon;Sanjay Modi;Lizi Wu;Akihito Kubo

  • Integrative Genomic Characterization of Oral Squamous Cell Carcinoma Identifies Frequent Somatic Drivers

    Curtis R. Pickering;Jiexin Zhang;Suk Young Yoo;Linnea Bengtsson

  • Predicting cancer development in oral leukoplakia: ten years of translational research.

    J. Jack Lee;Waun Ki Hong;Walter N. Hittelman;Li Mao

Frequent Co-Authors

John G. Batsakis
John G. Batsakis The University of Texas MD Anderson Cancer Center
Randal S. Weber
Randal S. Weber The University of Texas MD Anderson Cancer Center
Jeffrey N. Myers
Jeffrey N. Myers The University of Texas MD Anderson Cancer Center
Mario A. Luna
Mario A. Luna The University of Texas MD Anderson Cancer Center
Gary L. Clayman
Gary L. Clayman The University of Texas MD Anderson Cancer Center
Waun Ki Hong
Waun Ki Hong The University of Texas MD Anderson Cancer Center
David I. Rosenthal
David I. Rosenthal The University of Texas MD Anderson Cancer Center
Jae Y. Ro
Jae Y. Ro Cornell University
J. Jack Lee
J. Jack Lee The University of Texas MD Anderson Cancer Center
Nelson G. Ordóñez
Nelson G. Ordóñez The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering medical studies in the USA, online degrees can offer flexibility and targeted career advancement. Many professionals choose bridge programs, like adn to fnp bridge programs, which help registered nurses advance quickly to nurse practitioner roles without starting from scratch.

For those interested in nutrition, earning one of the online nutrition degrees opens doors to specialties in dietetics, wellness, and preventive healthcare. These degrees focus on evidence-based practice, food science, and patient counseling.

If your goal is to lead healthcare organizations, enrolling in one of the best mha programs can be an excellent step. These CAHME-accredited programs emphasize healthcare management, policy, and leadership, preparing graduates for administrative roles.

For busy working nurses, rn bsn online programs no clinicals streamline the path to a Bachelor of Science in Nursing—often without on-site clinical requirements. This can make it easier to balance education with your current work and family commitments.

Best Scientists Citing Adel K. El-Naggar

Trending Scientists

Recently Published Articles